New Orleans

A new treatment for COVID-19 is in clinical trials – New Orleans, Louisiana

New Orleans, Louisiana 2021-09-20 12:04:00 –

A new treatment for COVID-19 is underway. Linda Gorgos in Santa Fe, New Mexico is leading the trial of an experimental antiviral drug called molnupiravir. She says the drug shuts down the virus, preventing it from duplicating or copying itself. “The idea is to try to shut down the infection early before the infection begins, or if it is unlikely that it is already infected, before the disease is mildened,” Dr. Gogos said. “It’s a really exciting option to have to provide people with something as a prophylaxis because I’ve never received anything other than vaccination.” It’s an oral drug, so you don’t have to get an injection. In fact, its main use is for people who do not have the COVID-19 vaccine. “We know that people who are already vaccinated have that level of protection against getting infected with COVID-19 and getting infected,” said Dr. Gorgos. .. So how often do you have to be treated for it to be effective? Dr. Gogos said participants in the study would take the drug orally for 4-5 days to test the effect. She says the exam is already in the advanced stages. An opportunity to bring that science to New Mexico. Clinical trials currently only accept people over the age of 18. To qualify, you must belong to a household of 10 people or less. Watch the video above to learn more about this story.

A new treatment for COVID-19 is underway.

Dr. Linda Gorgos of Santa Fe, New Mexico is leading the trial of an experimental antiviral drug called molnupiravir. She says the drug shuts down the virus, preventing it from duplicating or copying itself.

“The idea is to try to shut down the infection early before the infection begins, or if it is unlikely that it is already infected, before the disease is mildened,” Dr. Gogos said. “Because I’ve never been vaccinated before, having to provide people with something as a precaution is a really exciting option.”

It’s an oral drug, so you don’t need to get an injection. In fact, its main use is for people who do not have the COVID-19 vaccine.

“We know that people who are already vaccinated have that level of protection against getting infected with COVID-19 and getting infected,” said Dr. Gorgos. ..

So how often do you have to be treated for it to be effective? Dr. Gogos said participants in the study would take the drug orally for 4-5 days to test the effect.

“COVID prophylaxis is really exciting for us and we are excited to have the opportunity to bring that science to New Mexico,” she said, saying the trial is already in its infancy.

Clinical trials currently only accept people over the age of 18. To qualify, you must belong to a household of 10 people or less.

Watch the video above to learn more about this story.

A new treatment for COVID-19 is in clinical trials Source link A new treatment for COVID-19 is in clinical trials

Back to top button